SCHEMBL5237985

SCHEMBL5237985

O=[N+]([O-])c1cccc(CBr)c1-c1c(CBr)cccc1[N+](=O)[O-]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
TSHR P16473 3/20 0.50
S100A4 P26447 2/20 0.50
TDP1 Q9NUW8 2/20 0.48
GPR35 Q9HC97 2/20 0.47
HPGD P15428 1/20 0.46
PTPRC P08575 1/20 0.46
RECQL P46063 2/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
MCL1 Q07820 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
ACHE P22303 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
HSD17B10 Q99714 1/20 0.41
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30100131 0.83 ALDH1A1 (0.64) ALDH1A1TSHRTDP1HPGDRECQL
SCHEMBL70062 0.83 ALDH1A1 (0.64) ALDH1A1TSHRTDP1HPGDRECQL
SCHEMBL1080995 0.82 ALDH1A1 (0.48) ALDH1A1TSHRS100A4TDP1GPR35
SCHEMBL29800736 0.82 ALDH1A1 (0.48) ALDH1A1TSHRS100A4TDP1GPR35
SCHEMBL1167739 0.82 TSHR (0.53) ALDH1A1TSHRS100A4TDP1GPR35
SCHEMBL1232315 0.82 ALDH1A1 (0.48) ALDH1A1TSHRS100A4TDP1GPR35
SCHEMBL30844575 0.82 ALDH1A1 (0.48) ALDH1A1TSHRS100A4TDP1GPR35
SCHEMBL28408586 0.82 S100A4 (0.46) ALDH1A1TSHRS100A4TDP1HPGD
SCHEMBL28408562 0.82 S100A4 (0.46) ALDH1A1TSHRS100A4TDP1GPR35
Iodide SCHEMBL9605320 0.82 ALDH1A1 (0.62) ALDH1A1TSHRTDP1HPGDRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263735-B1 ACID ADDITION SALTS OF IMIDAZOLIDINONES AS REACTION CATALYSTS UNIV CALIFORNIA (US) 2007-07-04 EP disclosed
EP-1002801-B1 Chiral diphenyldiphosphines and d-8 metal complexes thereof SOLVIAS AG (CH) 2003-06-18 EP disclosed
US-6534434-B2 Catalyst for unsaturated carbonyl compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-03-18 US disclosed
US-6515137-B2 Enantioselectivity of alpha,beta-unsaturated aldehydes THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-02-04 US disclosed
US-6369243-B1 ACID CATALYST THE REGENTS OF THE UNIVERISITY OF CALIFORNIA 2002-04-09 US disclosed
US-20020016473-A1 Catalytic processes employing chiral imidazolidinone-based catalyst composition MACMILLAN DAVID W C (US) 2002-02-07 US disclosed
US-20020013475-A1 Chiral imidazolidinone-based catalyst composition and reaction system MACMILLAN DAVID W C (US) 2002-01-31 US disclosed
US-6307057-B1 CATALYZE ENANTIOSELECTIVE REACTIONS, E.G., DIELS-ALDER REACTIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020013475-A1 Chiral imidazolidinone-based catalyst composition and reaction system COASY, DHPS, INTS9 ALDH1A1 78/4885TSHR 4061/4885S100A4 4431/4885
US-20020016473-A1 Catalytic processes employing chiral imidazolidinone-based catalyst composition COASY, ALDH3A1, TALDO1 ALDH1A1 40/4885TSHR 4574/4885S100A4 4208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.